(19)
(11) EP 1 210 448 A1

(12)

(43) Date of publication:
05.06.2002 Bulletin 2002/23

(21) Application number: 00949877.5

(22) Date of filing: 03.08.2000
(51) International Patent Classification (IPC)7C12N 15/869, A61K 39/245
(86) International application number:
PCT/IL0000/469
(87) International publication number:
WO 0109/361 (08.02.2001 Gazette 2001/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 03.08.1999 IL 13121299

(71) Applicants:
  • Yissum Research and Development Company of the Hebrew University of Jerusalem
    91042 Jerusalem (IL)
  • HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
    91120 Jerusalem (IL)

(72) Inventors:
  • BECKER, Yechiel
    94445 Jerusalem (IL)
  • ASHER, Yael
    90805 Mevaseret Zion (IL)
  • BUJANOVER, Sergey
    93826 Jesuralem (IL)
  • BEN-HUR, Tamir
    96920 Jerusalem (IL)
  • DARAI, Gholamreza,Ruprecht Karls U. Heidelberg
    69117 Heidelberg (DE)
  • KEHM, RolandRuprecht Karls Universität Heidelberg
    69117 Heidelberg (DE)
  • MOYAL, Michal
    96920 Jerusalem (IL)
  • ROSEN-WOLFF, Angela
    01326 Dresden (DE)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) RECOMBINANT HSV-1 AND LIVE VIRAL VACCINES